Like a modern-day Rip Van Winkle, I returned to the claims analytics industry in 2017 after a decade-long hiatus. Unlike Rip Van Winkle, I recently discovered that nothing has changed about the fascination that health system executives have with “state data”.
With the announcement by the Department of Health and Human Services (HHS) of the January 1, 2019 effective date of new, and lower, payments for drugs acquired under the 340B program, I was reminded of a post that my friend Wes Chapman published a little more than a..
Market share is “top of mind” for every savvy health system executive in America, even if definitions of market share are imprecise. Most often, health system executives think about market share in terms of the “PSA” and “SSA”, which is an elegant way of referring..
Status quo, as everyone knows, is Latin for the existing state of affairs, particularly in a political context. Ironically, the reliance on governmental and political organizations as the source of data analytics is the status quo for thousands of U.S. hospitals.